IN and OUT Licensing
IBI is approved for the production of drugs for top markets such as Europe, the United States and Asia, and offers a wide range of products for registration or distribution abroad through international partners.
IBI offers a wide range of injectable and oral products in various treatment areas: gastroenterology, inflammation and pain, nutraceuticals and anti-infectious drugs. Furthermore, it constantly invests in the development of new dossiers and the production of new therapy opportunities.
Through a sales network present in Italy, Germany, the United Kingdom and Ireland, and distribution partners in other countries, today IBI is present in over 20 countries and interested in assessing new licensed product opportunities.
For more information on the products available for licensing out, or to propose products to add to the licensing-in sales structure, you can contact:
IBI offers formula development and various medical speciality and pharmaceutical form production services, including biotechnologies, proteins and nanoparticle delivery systems.
For more information on pharmaceutical development opportunities, visit the Biopharmaceutical R&D Services page or contact:
Please send non-confidential information only. Please read our Privacy & Cookies Policy before sending a partnership proposal.